Trials / Active Not Recruiting
Active Not RecruitingNCT05597267
The MIRIA Acne Scar Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- AVAVA, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MIRIA Laser | 4-6 experimental treatments at 4-6 weeks intervals |
Timeline
- Start date
- 2022-11-04
- Primary completion
- 2025-02-28
- Completion
- 2025-02-28
- First posted
- 2022-10-28
- Last updated
- 2025-03-07
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05597267. Inclusion in this directory is not an endorsement.